SUNIL AGARWAL - 08 Apr 2024 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATXS	Stock Option (Right to Buy)	Award	$0	+28,200		$0.000000	28,200	08 Apr 2024	Common Stock	28,200	$11.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted on April 8, 2024 and is scheduled to vest as to one-third of the shares of common stock underlying the option on each anniversary of the grant date until the third anniversary of the grant date, subject to the director's continued service.